6-(3,4-Dimethoxyphenyl)-3-(pyridin-4-yl)imidazo[1,2-b]-pyridazine

ID: ALA3234041

Chembl Id: CHEMBL3234041

PubChem CID: 90670243

Max Phase: Preclinical

Molecular Formula: C19H16N4O2

Molecular Weight: 332.36

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1ccc(-c2ccc3ncc(-c4ccncc4)n3n2)cc1OC

Standard InChI:  InChI=1S/C19H16N4O2/c1-24-17-5-3-14(11-18(17)25-2)15-4-6-19-21-12-16(23(19)22-15)13-7-9-20-10-8-13/h3-12H,1-2H3

Standard InChI Key:  RGCBNZMZILWLBO-UHFFFAOYSA-N

Associated Targets(Human)

Liver microsome (8277 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Plasmodium falciparum (966862 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Scyl1 N-terminal kinase-like protein (54 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Beta-TC6 (562 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
C2C12 (756 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 332.36Molecular Weight (Monoisotopic): 332.1273AlogP: 3.48#Rotatable Bonds: 4
Polar Surface Area: 61.54Molecular Species: NEUTRALHBA: 6HBD:
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 4.52CX LogP: 2.72CX LogD: 2.72
Aromatic Rings: 4Heavy Atoms: 25QED Weighted: 0.57Np Likeness Score: -1.28

References

1. Le Manach C, Gonzàlez Cabrera D, Douelle F, Nchinda AT, Younis Y, Taylor D, Wiesner L, White KL, Ryan E, March C, Duffy S, Avery VM, Waterson D, Witty MJ, Wittlin S, Charman SA, Street LJ, Chibale K..  (2014)  Medicinal chemistry optimization of antiplasmodial imidazopyridazine hits from high throughput screening of a SoftFocus kinase library: part 1.,  57  (6): [PMID:24568587] [10.1021/jm500098s]
2.  (2014)  Nitrogen bicyclic compounds as inhibitors for Scyl1 and Grk5,